Pediatrix Medical Group, Inc. (MD) Documents: SEC Filings, Investor Presentations & Press Releases

Pediatrix Medical Group, Inc. (MD) documents, SEC filings and the IR site together: 76 documents, newest first; latest 2026-08-04. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site

Date	Type	Document
2026-08-04	8-K	Form 8-K, Item 2.02 results
2026-08-04	10-Q	Form 10-Q for the quarter ended Jun 30
2026-07-24	8-K	Form 8-K, Item 5.02
2026-07-15	8-K	Form 8-K, Item 2.02 results
2026-05-07	8-K	Form 8-K, Item 5.02
2026-05-05	8-K	Form 8-K, Item 2.02 results
2026-05-05	10-Q	Form 10-Q for the quarter ended Mar 31
2026-03-27	Proxy	Definitive proxy statement
2026-02-23	Transcript	Q4 FY25 earnings call transcript
2026-02-19	8-K	Form 8-K, Item 2.02 results
2026-02-19	10-K	Annual report on Form 10-K, FY25
2026-01-08	ESG report	Pediatrix Medical Group sustainability · FY 2024
2025-11-03	8-K	Form 8-K, Item 2.02 results
2025-11-03	10-Q	Form 10-Q for the quarter ended Sep 30
2025-08-18	8-K	Form 8-K, Item 7.01
2025-08-05	8-K	Form 8-K, Item 2.02 results
2025-08-05	10-Q	Form 10-Q for the quarter ended Jun 30
2025-07-01	8-K	Form 8-K, Item 5.02
2025-05-08	8-K	Form 8-K, Item 5.07
2025-05-06	8-K	Form 8-K, Item 2.02 results
2025-05-06	10-Q	Form 10-Q for the quarter ended Mar 31
2025-04-18	8-K	Form 8-K, Item 1.01
2025-03-28	Proxy	Definitive proxy statement
2025-02-20	8-K	Form 8-K, Item 2.02 results
2025-02-20	10-K	Annual report on Form 10-K, FY24
2025-01-14	8-K	Form 8-K, Item 5.02
2025-01-13	8-K	Form 8-K, Item 2.02 results
2024-12-05	8-K	Form 8-K, Item 5.02
2024-11-01	8-K	Form 8-K, Item 2.02 results
2024-11-01	10-Q	Form 10-Q for the quarter ended Sep 30
2024-08-06	8-K	Form 8-K, Item 2.02 results
2024-08-06	10-Q	Form 10-Q for the quarter ended Jun 30
2024-06-17	8-K	Form 8-K, Item 5.02
2024-05-30	8-K	Form 8-K, Item 7.01
2024-05-09	8-K	Form 8-K, Item 5.07
2024-05-07	8-K	Form 8-K, Item 2.02 results
2024-05-07	10-Q	Form 10-Q for the quarter ended Mar 31
2024-04-25	8-K	Form 8-K, Item 1.01
2024-03-28	Proxy	Definitive proxy statement
2024-02-20	8-K	Form 8-K, Item 2.02 results

MD overview · MD earnings · MD financials · MD KPIs · MD ownership · MD peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.